Ezintsha is a group of South African academics and health professionals who work with partners around the world. We apply new technology to health-related problems, and work to extend access to effective drugs so that quality health care and medicine is available to everyone. Ezintsha is a newly formed sub-division of Wits Reproductive Health & HIV Institute, which is part of the University of the Witwatersrand, based in Johannesburg, South Africa. Ezintsha builds on the success of the Wits Reproductive Health & HIV Institute (Wits RHI ), an internationally recognised research entity focused on Sexual & Reproductive Health (SRH), Vaccine Preventable Diseases (VPDs) and HIV. Wits RHI has always encouraged entrepreneurialism and Ezintsha is the latest entity to emerge from this strong foundation and develop new areas of research excellence. Our areas of expertise include: Treatment optimisation, affordable access to drugs and self-care – including TB, oncology and rheumatology as well as HIV Diversification of the current medical technologies portfolio from self-testing to diagnostics more broadly, in line with WHO strategies Patient monitoring and management systems to support a broader public health improvement agenda Patient-centric, technology-enabled, clinical research innovations with a focus on clinical excellence Mental health, diabetes, oncology, hypertension and strategic approaches to chronic conditions Support to other government priorities, such as transport health (taxi drivers, truckers) Ezintsha is privileged to have a first-class team of experienced healthcare experts and researchers on board. We are led by Professor Francois Venter, a well-known infectious diseases and HIV doctor.